Platelet activation responses in vitro to human mast cell activation

Citation
C. Gardiner et al., Platelet activation responses in vitro to human mast cell activation, BR J HAEM, 106(1), 1999, pp. 208-215
Citations number
40
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BRITISH JOURNAL OF HAEMATOLOGY
ISSN journal
00071048 → ACNP
Volume
106
Issue
1
Year of publication
1999
Pages
208 - 215
Database
ISI
SICI code
0007-1048(199907)106:1<208:PARIVT>2.0.ZU;2-0
Abstract
Mast cells are thought to play an important role in atherogenesis and plaqu e rupture, but their role in the subsequent platelet activation and thrombu s formation is unclear. Tryptase positive cells (KU812(T+)) were establishe d from the KU812 cell line as an in vitro model of human mast cells and use d to study the effect of mast cell activation on human platelets, Overnight incubation of KU812(T+) with IgE and subsequent challenge with anti-IgE ca used the release of heparinoid substances which inhibited 1 mu g/ml collage n-induced platelet aggregation. KU812(T+) challenged with compound 48/80 pr oduced a releasate that had no apparent heparinoid content but caused full platelet aggregation. These findings showed that, although activation of KU 812(T+) via Fc epsilon R1 partially abrogated collagen-induced platelet agg regation, activation of the C5a receptor signalling pathway, by compound 48 /80, caused the release of potent platelet-activating substances. This cell culture model offers a unique insight into the role of platelet-mast cell interactions in arterial thrombogenesis.